Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Internal Medicine)
Gastroenterologist
MBBS, FCPS Gastroenterology
Family Physician
MBBS (pak) , FCPS (pak) , MRCGP (UK), MRCS (UK), CCT (UK) , PG CERT, Diabetes (UK), MCFPC (Canada)
Family Physician
MBBS (pak) , FCPS (pak) , MRCGP (UK), MRCS (UK), CCT (UK) , PG CERT, Diabetes (UK), MCFPC (Canada)
Nephrologist
MBBS, Diplomate American Board Nephrology
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Pulmonologist
M.B.B.S., F.C.P.S. (Medicine), F.C.P.S. (Pulomonogy)
Internal Medicine Specialist
MBBS, MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
MBBS, MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
General Physician
MBBS, FRACGP (Australia), Professional Certificate in Women Helath (Australia)
General Physician
MBBS, FRACGP (Australia), Professional Certificate in Women Helath (Australia)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures